牛牛AI助理已提取核心訊息
Moderna, Inc. officer Stephen Hoge is set to sell 2,388 shares of common stock on 02/29/2024, with an aggregate market value of $225,837.93. The shares were acquired on 02/28/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 87,291 shares were sold for gross proceeds of $8,637,222.77.
Moderna, Inc. officer Stephen Hoge is set to sell 2,388 shares of common stock on 02/29/2024, with an aggregate market value of $225,837.93. The shares were acquired on 02/28/2024 as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 87,291 shares were sold for gross proceeds of $8,637,222.77.
Moderna, Inc.高管斯蒂芬·霍格定於2024年2月29日出售2388股普通股，總市值爲225,837.93美元。這些股票於2024年2月28日作爲限制性股票歸屬的一部分收購，被視爲發行人的補償。該交易是在過去三個月進行的一系列銷售之後進行的，共出售了87,291股股票，總收益爲8,637,222.77美元。
Moderna, Inc.高管斯蒂芬·霍格定於2024年2月29日出售2388股普通股，總市值爲225,837.93美元。這些股票於2024年2月28日作爲限制性股票歸屬的一部分收購，被視爲發行人的補償。該交易是在過去三個月進行的一系列銷售之後進行的，共出售了87,291股股票，總收益爲8,637,222.77美元。
有用
沒用